These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16944103)

  • 1. Impaired in vivo venous constriction in conscious obese Zucker rats with metabolic syndrome.
    Song D; Hutchings SR; Pang CC
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Sep; 373(6):451-6. PubMed ID: 16944103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of N omega-nitro-L-arginine methyl ester, sodium nitroprusside and noradrenaline on venous return in the anaesthetized cat.
    Bower EA; Law AC
    Br J Pharmacol; 1993 Apr; 108(4):933-40. PubMed ID: 8485632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of noradrenaline-induced vasoconstriction in isolated perfused mesenteric arterial beds from obese Zucker rats in the presence and absence of insulin.
    He Y; MacLeod KM
    Can J Physiol Pharmacol; 2002 Mar; 80(3):171-9. PubMed ID: 11991227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered nitroxidergic and NMDA receptor-mediated modulation of baroreflex-mediated heart rate in obese Zucker rats.
    Chen JS; Wang HJ; Chang WC; Jao CC; Wu BT; Shyu WC; Lee SD
    Hypertens Res; 2010 Sep; 33(9):932-6. PubMed ID: 20555326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered renal microvascular response in Zucker obese rats.
    Hayashi K; Kanda T; Homma K; Tokuyama H; Okubo K; Takamatsu I; Tatematsu S; Kumagai H; Saruta T
    Metabolism; 2002 Dec; 51(12):1553-61. PubMed ID: 12489067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo and in vitro evidence of altered nitric oxide metabolism in the spontaneously diabetic, insulin-dependent BB/Edinburgh rat.
    Lindsay RM; Peet RS; Wilkie GS; Rossiter SP; Smith W; Baird JD; Williams BC
    Br J Pharmacol; 1997 Jan; 120(1):1-6. PubMed ID: 9117082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclooxygenase-2 preserves flow-mediated remodelling in old obese Zucker rat mesenteric arteries.
    Belin de Chantemèle EJ; Vessières E; Guihot AL; Toutain B; Loufrani L; Henrion D
    Cardiovasc Res; 2010 Jun; 86(3):516-25. PubMed ID: 20032084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of chronic treatment with the CB1 antagonist, rimonabant on the blood pressure, and vascular reactivity of obese Zucker rats.
    Mingorance C; Alvarez de Sotomayor M; Jiménez-Palacios FJ; Callejón Mochón M; Casto C; Marhuenda E; Herrera MD
    Obesity (Silver Spring); 2009 Jul; 17(7):1340-7. PubMed ID: 19553924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular wall dysfunction in JCR:LA-cp rats: effects of age and insulin resistance.
    O'brien SF; Russell JC; Davidge ST
    Am J Physiol; 1999 Nov; 277(5):C987-93. PubMed ID: 10564092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats.
    Rivera L; Morón R; Sánchez M; Zarzuelo A; Galisteo M
    Obesity (Silver Spring); 2008 Sep; 16(9):2081-7. PubMed ID: 18551111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased NO signaling leads to enhanced vasoconstrictor responsiveness in skeletal muscle arterioles of the ZDF rat prior to overt diabetes and hypertension.
    Lesniewski LA; Donato AJ; Behnke BJ; Woodman CR; Laughlin MH; Ray CA; Delp MD
    Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1840-50. PubMed ID: 18245568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between nitric oxide and renal nerves in the excretion of a saline load in obese Zucker rats.
    Wongmekiat O; Johns EJ
    Clin Sci (Lond); 2001 Sep; 101(3):275-83. PubMed ID: 11524045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of basal endothelial function in the obese Zucker rat in vitro.
    Laight DW; Anggård EE; Carrier MJ
    Gen Pharmacol; 2000 Dec; 35(6):303-9. PubMed ID: 11922960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered vasodilator role of nitric oxide synthase in the pancreas, heart and brain of rats with spontaneous type 2 diabetes.
    Song D; Yao R; Pang CC
    Eur J Pharmacol; 2008 Sep; 591(1-3):177-81. PubMed ID: 18585382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired insulin-induced attenuation of noradrenaline-mediated vasoconstriction in insulin-resistant obese Zucker rats.
    Walker AB; Dores J; Buckingham RE; Savage MW; Williams G
    Clin Sci (Lond); 1997 Sep; 93(3):235-41. PubMed ID: 9337638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered insulin-mediated and insulin-like growth factor-1-mediated vasorelaxation in aortas of obese Zucker rats.
    Yang AL; Chao JI; Lee SD
    Int J Obes (Lond); 2007 Jan; 31(1):72-7. PubMed ID: 16682977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute hypertension after nitric oxide synthase inhibition is mediated primarily by increased endothelin vasoconstriction.
    Banting JD; Friberg P; Adams MA
    J Hypertens; 1996 Aug; 14(8):975-81. PubMed ID: 8884552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic response to norepinephrine with and without inhibition of nitric oxide synthase in porcine endotoxemia.
    Datta P; Magder S
    Am J Respir Crit Care Med; 1999 Dec; 160(6):1987-93. PubMed ID: 10588618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased vasoconstriction to noradrenaline by 1400W, inhibitor of iNOS, in rats with streptozotocin-induced diabetes.
    Cheng X; Pang CC
    Eur J Pharmacol; 2004 Jan; 484(2-3):263-8. PubMed ID: 14744612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective inhibition of pressor and haemodynamic effects of NG-nitro-L-arginine by halothane.
    Wang YX; Abdelrahman A; Pang CC
    J Cardiovasc Pharmacol; 1993 Oct; 22(4):571-8. PubMed ID: 7505359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.